Pulmonx Corporation

Pulmonx Corporation

LUNG · Nasdaq

Pulmonx Corporation (LUNG) is a Medical devices company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Pulmonx Corporation in 2026. The next earnings report is expected on November 4, 2026.

Earnings calendar

Next earnings date

04 Nov 2026

In 76 days

EPS estimate

-0.26

Revenue estimate

21.9M

Past earnings

29 Jul 2026
EPS actual
-0.24 (+14.3%)
estimate -0.28
Revenue actual
22.8M (+1.6%)
estimate 22.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
29 Apr 2026
EPS actual
-0.33 (-1.0%)
estimate -0.33
Revenue actual
20.6M (+0.8%)
estimate 20.4M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
04 Mar 2026
EPS actual
-0.25 (+35.1%)
estimate -0.39
Revenue actual
22.6M (+4.0%)
estimate 21.7M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Latest earnings analysis

Pulmonx Corporation beat consensus estimates in its latest earnings report, with EPS of -$0.24 versus expectations of -$0.28 and revenue of $22.76 million exceeding estimates by 1.6%. In the prior quarter EPS missed expectations while revenue came in ahead of estimates by 0.8%.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

Sector
Healthcare
Industry
Medical devices
Country
United States
Exchange
Nasdaq
CEO
Glendon E. French
Employees
291
IPO date
01 Oct 2020
ISIN
US7458481014
Website
pulmonx.com

Frequently asked questions

When does Pulmonx Corporation (LUNG) next report earnings?

Pulmonx Corporation (LUNG) is scheduled to report earnings on November 4, 2026.

What was Pulmonx Corporation's most recent earnings date?

Pulmonx Corporation (LUNG) last reported earnings on July 29, 2026.

Where is Pulmonx Corporation stock listed?

Pulmonx Corporation (LUNG) is listed on Nasdaq.